Glucagon-like peptide-1 (GLP-1) receptor agonists are peptide-based therapeutics for treating diabetes and for weight loss.

Sanofi has agreed to acquire DR-0201, a targeted bispecific myeloid cell engager, from Dren Bio Inc. for $600 million upfront ...

Sanofi SA is getting deeper into oncology and immunology therapy development through buying Dren Bio Inc.’s myeloid cell engager for deep B-cell depletion, DR-0201. The deal could reach as high as $1.

Sanofi’s move for Dren Bio’s clinical asset boosts its immunology-focused strategy of becoming a leader in the field.

Sanofi SNY announced that it signed an agreement with California-based privately held biopharmaceutical company Dren Bio to ...

The antigen-binding site of the antibody has a unique structure that allows it to bind antigen in a highly specific manner. Functional and structural studies of two potent antibodies isolated from ...

Tryptic peptides were dissolved in NETN buffer (100 mM NaCl, 1 mM EDTA, 50 mM Tris-HCl, 0.5% NP-40, pH 8.0) and incubated overnight at 4°C with gentle shaking, using pre-washed anti-L-lactyl lysine ...

FIGURE 1. Binding surfaces identification and separation into connected components for Human Hedgehog acyltransferase in complex with two Fab antibody fragments (pdb code: 7MHY). In cyan the surface ...

Over 1.3 crore people visited the Maha Kumbh on Monday itself. The Maha Kumbh Mela commenced on January 13. The month-long celebration of Maha Kumbh, one the world’s largest religious gatherings, ...

Type 1 diabetes occurs when the immune system attacks pancreatic beta cells. Type 2 diabetes happens when the body cannot use insulin effectively. The two types differ in symptoms, causes ...

Get Instant Summarized Text (Gist) Approximately 10% of South Asian immigrants aged 45 and older in Canada have hypothyroidism, with a 77% higher likelihood compared to Canadian-born individuals ...